Day: May 6, 2020

Revenue was on par with our expectations, while a strong focus on improved profitability resulted in an EBITA above our expectations. Like other companies, Solar is affected by the challenges caused by the COVID-19 pandemic. However, Solar has an agile business model and is fundamentally a digital business, which means that we are well positioned for the next normal.CEO Jens Andersen says:“We are pleased to see that EBITA from core business was up by more than 20% in Q1 and thereby exceeded our expectations. Like other companies, Solar is affected by the challenges caused by the COVID-19 pandemic, and we experienced a limited effect in April with a decline in group revenue resulting in a negative organic growth of -1.6%.Solar has an agile business model with strong supplier partnerships, a high and ever-increasing share of e-business...

Omsætningen var på niveau med forventningerne, mens et stærkt fokus på forbedret lønsomhed resulterede i EBITA over vores forventninger. Ligesom andre selskaber er Solar påvirket af de udfordringer, som COVID-19-pandemien forårsager. Solar har dog en agil forretningsmodel og er grundlæggende en digital forretning, hvilket betyder, at vi er godt positioneret i forhold til ”next normal”.CEO Jens Andersen udtaler:”Vi glæder os over, at EBITA fra kerneforretningen steg med over 20% i Q1 og dermed overgik vores forventninger. Ligesom andre selskaber er Solar påvirket af de udfordringer, som COVID-19-pandemien forårsager, og vi har set en begrænset effekt i april med et fald i koncernomsætningen, der resulterede i en negativ organisk vækst på -1,6%.Solar har en agil forretningsmodel med stærke leverandørsamarbejder, en høj og støt stigende...

Company AnnouncementCopenhagen, 06 May 2020No. 09/2020TRADING UPDATE FOR 1 JANUARY – 31 MARCH 2020:ISS (ISS.CO, ISS DC, ISSDY), a leading workplace experience and facility management company, announces its trading update for Q1 2020:HighlightsRevenue increased by 2.4% year-over-year in Q1 2020 with solid organic growth of 4.1% driven in particular by key account organic growth of 9.1% and strong demand for deep-cleaning and disinfection services.Our number one priority is the health and safety of our colleagues. At the same time, we are taking a central role in the business continuity plans of thousands of customers around the world.With the COVID-19 crisis unfolding, we have seen an increasing impact on our operations over the last weeks. The estimated negative organic growth in April was around 20%. In isolation the estimated negative...

Estimated sales growth adjusted for COVID-19-related stocking around 7% at CERSales in International Operations increased by 19% in Danish kroner (19% at CER), driven by growth in all areas. Sales in North America Operations increased by 12% in Danish kroner (9% at CER). In both operating units, sales were impacted by COVID-19-related stocking.Sales within Diabetes and Obesity care increased by 15% to DKK 28.6 billion (14% at CER), driven by Diabetes care growing by 13% at CER and Obesity care growing by 30% at CER. Sales within Biopharm increased by 18% to DKK 5.3 billion (16% at CER).Sales of GLP-1 increased by 40% in Danish kroner (37% at CER) reflecting the solid uptake of Ozempic®. In the US, Rybelsus® market access is progressing and the weekly new-to-brand market share has reached 8.8%.The pipeline progressed with approval of Rybelsus®...

Netcompany grew in line with expectations and realised 23.6% adjusted EBITA margin while increasing free cash flow by 26.4%. Netcompany maintains its expectations for 2020.Company announcementNo. 8/202006 May 2020SummaryIn Q1 2020, Netcompany realised reported revenue of DKK 695.6m, corresponding to 16.4% (constant currencies 16.8%) growth in reported currencies and organic revenue growth of 13.4%. Adjusting for the impact of the contingency risk in Q1 2019 revenue grew by 18.3%.Adjusted EBITA margin, excluding the non-organic impact from the Netherlands, was 24.1%. Adjusting for the impact of the contingency risk, organic adjusted EBITA margin increased by 0.7% points.The average number of full-time employees grew by 23.2% from 2,099 in Q1 2019 to 2,585 in Q1 2020. Part of the increase was related to the acquisition of Netcompany Netherlands,...

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) today released its financial and operating results and related management’s discussion and analysis for the three months ended March 31, 2020.Corporate UpdateIn the April 2, 2020 press release, IPC revised its forecast 2020 net average production to be in the range of 30,000 to 45,000 barrels of oil equivalent (boe) per day (boepd), estimated operating costs for 2020 to be in the range of USD 12 to 13 per boe, and reductions in total forecast 2020 expenditure of between USD 125 and 190 million as compared to estimates announced at IPC’s Capital Markets Day (CMD) in February 2020.Operational decisions that IPC has subsequently made allow it to revise the forecast 2020 expenditure reductions to between USD 175 and 190 million as compared to CMD estimates....

SUNNYVALE, Calif. , May 05, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the pricing of an underwritten public offering of 6,808,154 shares of its common stock at a public offering price of $39.00 per share, before deducting underwriting discounts and commissions. 1,923,076 shares in the offering are being offered for sale by Silk Road Medical, and 4,885,078 shares are being offered for sale by certain selling securityholders. In addition, the selling securityholders have granted the underwriters a 30-day option to purchase up to an additional 1,021,223 shares of common stock at the public offering price, less the underwriting discounts and commissions. The gross proceeds from the offering to Silk...